156 related articles for article (PubMed ID: 18270432)
41. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
Filippatos TD; Tsimihodimos V; Derdemezis CS; Gazi IF; Saougos V; Mikhailidis DP; Tselepis AD; Elisaf MS
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):330-6. PubMed ID: 21963513
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans.
Choi HJ; Cho YM; Moon MK; Choi HH; Shin HD; Jang HC; Kim SY; Lee HK; Park KS
J Clin Endocrinol Metab; 2006 Nov; 91(11):4657-63. PubMed ID: 16954159
[TBL] [Abstract][Full Text] [Related]
43. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
[TBL] [Abstract][Full Text] [Related]
44. A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.
Blakemore AI; Meyre D; Delplanque J; Vatin V; Lecoeur C; Marre M; Tichet J; Balkau B; Froguel P; Walley AJ
Obesity (Silver Spring); 2009 Aug; 17(8):1549-53. PubMed ID: 19300429
[TBL] [Abstract][Full Text] [Related]
45. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
[TBL] [Abstract][Full Text] [Related]
46. Association of TNF-alpha gene promoter C-857T polymorphism with higher serum LDL cholesterol levels and carotid plaque formation in Japanese patients with type 2 diabetes.
Yamashina M; Kaneko Y; Maesawa C; Kajiwara T; Ishii M; Fujiwara F; Taneichi H; Takebe N; Ishida W; Takahashi K; Masuda T; Satoh J
Tohoku J Exp Med; 2007 Mar; 211(3):251-8. PubMed ID: 17347550
[TBL] [Abstract][Full Text] [Related]
47. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.
Sandeep S; Velmurugan K; Deepa R; Mohan V
Metabolism; 2007 Apr; 56(4):565-70. PubMed ID: 17379018
[TBL] [Abstract][Full Text] [Related]
48. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.
Chien KL; Chen MF; Hsu HC; Su TC; Chang WT; Lee CM; Lee YT
Clin Chim Acta; 2008 Feb; 388(1-2):78-83. PubMed ID: 17964293
[TBL] [Abstract][Full Text] [Related]
49. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
Cerda A; Genvigir FD; Arazi SS; Hirata MH; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
Clin Chim Acta; 2010 May; 411(9-10):631-7. PubMed ID: 20064494
[TBL] [Abstract][Full Text] [Related]
50. Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus.
Porchay-Baldérelli I; Péan F; Emery N; Maimaitiming S; Bellili N; Travert F; Mohammedi K; Roussel R; Marre M; Fumeron F;
Metabolism; 2009 Jan; 58(1):74-9. PubMed ID: 19059534
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations.
McCarthy JJ; Lewitzky S; Reeves C; Permutt A; Glaser B; Groop LC; Lehner T; Meyer JM
Hum Hered; 2003; 55(4):163-70. PubMed ID: 14566094
[TBL] [Abstract][Full Text] [Related]
52. Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study.
Retnakaran R; Youn BS; Liu Y; Hanley AJ; Lee NS; Park JW; Song ES; Vu V; Kim W; Tungtrongchitr R; Havel PJ; Swarbrick MM; Shaw C; Sweeney G
Clin Endocrinol (Oxf); 2008 Dec; 69(6):885-93. PubMed ID: 18410550
[TBL] [Abstract][Full Text] [Related]
53. Dietary fat intake associated with bone mineral density among visfatin genotype in obese people.
Khorrami-Nezhad L; Mirzaei K; Maghbooli Z; Keshavarz SA
Br J Nutr; 2018 Jan; 119(1):3-11. PubMed ID: 29355093
[TBL] [Abstract][Full Text] [Related]
54. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
Grarup N; Andreasen CH; Andersen MK; Albrechtsen A; Sandbaek A; Lauritzen T; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2008 Jun; 93(6):2294-9. PubMed ID: 18364377
[TBL] [Abstract][Full Text] [Related]
55. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
[TBL] [Abstract][Full Text] [Related]
56. Lack of association of ghrelin precursor gene variants and percentage body fat or serum lipid profiles.
Martin GR; Loredo JC; Sun G
Obesity (Silver Spring); 2008 Apr; 16(4):908-12. PubMed ID: 18239581
[TBL] [Abstract][Full Text] [Related]
57. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
[TBL] [Abstract][Full Text] [Related]
58. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
59. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes.
Osawa H; Onuma H; Murakami A; Ochi M; Nishimiya T; Kato K; Shimizu I; Fujii Y; Ohashi J; Makino H
Diabetes; 2002 Mar; 51(3):863-6. PubMed ID: 11872693
[TBL] [Abstract][Full Text] [Related]
60. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
